This polyclonal antibody recognizes the shortened isoform of the TDP43 protein that is involved in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.
| Inventor | Institute |
|---|---|
| Sami Barmada | University of Michigan |
| Cat. #: | 157962 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Neurobiology |
| Application: | IHC ; WB |
| Target: | Shortened TAR DNA-binding protein of 43 kDa (sTDP43) |
| Host: | Rabbit |
| Class: | Polyclonal |
| Product description: | This polyclonal antibody recognizes the shortened isoform of the TDP43 protein that is involved in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. |
|---|---|
| Conjugation: | Unconjugated |
| Immunogen: | EGFP fused to the 18-amino acid C-terminus of sTDP43 |
| Immunogen Uniprot ID: | TADBP_HUMAN |
| Target background: | This polyclonal antibody recognizes the shortened isoform of the TDP43 protein that is involved in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Weskamp et al. 2020. J Clin Invest. 130(3):1139-1155. PMID: 31714900. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151034 | Anti-HSVUL42 [13D11] |
Key Info
Anti-HSVUL42 [13D11]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.